Latest
Sierra x Acquired NYC: Bret Taylor on the AI ParadoxSierra x Acquired NYC: Bret Taylor on the AI Paradox|Clair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable EraClair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable Era|Orthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI AgentsOrthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI Agents|Tugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era ProblemTugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era Problem|fomo Raises $75M Series B as Social Trading Moves Mainstreamfomo Raises $75M Series B as Social Trading Moves Mainstream|DropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug DiscoveryDropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug Discovery|HistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the MainstreamHistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the Mainstream|Upscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats UpUpscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats Up|Nura Bio Raises $73.8M Series B to Advance SARM1 NeuroprotectionNura Bio Raises $73.8M Series B to Advance SARM1 Neuroprotection|Vedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine TherapiesVedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine Therapies|Sierra x Acquired NYC: Bret Taylor on the AI ParadoxSierra x Acquired NYC: Bret Taylor on the AI Paradox|Clair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable EraClair Health Raises $11.6M Seed to Bring Continuous Hormone Monitoring Into the Wearable Era|Orthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI AgentsOrthogonal Raises $4.3M Seed to Build the Infrastructure Layer for AI Agents|Tugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era ProblemTugboat Raises $3M Seed Round as Insurance Claims Become a Climate-Era Problem|fomo Raises $75M Series B as Social Trading Moves Mainstreamfomo Raises $75M Series B as Social Trading Moves Mainstream|DropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug DiscoveryDropGenie’s Seed+ Round Signals a New Era for Primary-Cell Drug Discovery|HistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the MainstreamHistoSonics Raises $250M in Growth Financing as Histotripsy Moves Into the Mainstream|Upscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats UpUpscale AI Raises $190M Series A at a $2B Valuation as the Battle for AI Networking Heats Up|Nura Bio Raises $73.8M Series B to Advance SARM1 NeuroprotectionNura Bio Raises $73.8M Series B to Advance SARM1 Neuroprotection|Vedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine TherapiesVedana Therapeutics Raises $46M Series A to Advance Next-Generation Migraine Therapies
Back to articles

5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services

Firms still raise capital with the same energy a regional bank manager uses explaining a certificate of deposit. Beige walls. Beige language. Beige ambition. Then there’s 5th Century Partners walking into the room with a $276M Fund II close and the kind of momentum that makes people suddenly “circle back” a lot faster.

Chicago has always understood industry. Steel. Freight. Trading floors full of caffeine and controlled chaos. So it feels right that Bruce Hampton, Marques Torbert, and Jessica Patton built 5th Century Partners there instead of somewhere decorated with eucalyptus water. The firm is focused on lower middle market healthcare and business services companies, the kind of businesses most people ignore until they realize those companies quietly keep the economy from face-planting into traffic.

That’s the game here. Not chasing noise. Chasing durable cash flow, operational leverage, and founders who actually know how to run companies instead of treating EBITDA like a spiritual concept. 5th Century Partners targets businesses generating $2M–$20M in EBITDA and writes equity checks ranging from $5M–$50M. They’re backing operators who understand execution and accountability.

Fund II nearly doubled the size of Fund I, which closed at $144M in 2022. Now the firm sits north of $550M in assets under management across funds and co-investment vehicles. That doesn’t happen because somebody slapped “AI” on a pitch deck and dimmed the lights. Institutional investors do not hand over checks that size because the vibes were immaculate. Endowments, pension plans, insurance companies, family offices, and corporations saw a machine with discipline under the hood.

And while half the market spent the last few years acting like free money would last forever, 5th Century Partners kept building in sectors where reality still matters. Healthcare services. Business services. Companies with actual customers. Actual margins. Actual consequences if operations break for 15 minutes on a Tuesday.

The firm has already deployed roughly 42% of Fund II into platform investments including Capstone Hospice, My Favorite Therapists, and Southern Paving & Milling. One helps people navigate end-of-life care. One supports mental health. One literally builds roads. That portfolio tells you everything about how Bruce Hampton, Marques Torbert, and Jessica Patton see the market. Less theater. More infrastructure. More businesses with fingerprints on the real world.

Credit also belongs to the broader team including Joseph Ayisi, Chase Culbertson, Dino Swan, Luke Bucshon, Will Smith, Chad Switzer, Christina Compere, Katherine Ho, Levon Keller-Chavez, Tyler Dray, Daniela Valenciana, and Tayler Sain. Firms do not scale because one person talks well on CNBC. They scale because operators and finance leaders stack disciplined decisions until momentum starts sounding like thunder.